Rose is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an editor.
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Short-Course Antibiotic Therapy for Community-Acquired Pneumonia as Effective as Long-Course Therapy
August 28th 2022The real-world study adds to previous randomized controlled trial findings suggesting that shorter courses of antibiotic therapy can be sufficient for hospitalized patients with mild or moderate community-acquired pneumonia.
Read More
TKI Therapy for Chronic-Phase CML Leads to Comparable Outcomes for AYAs and Older Adults
August 28th 2022A retrospective study found that adolescents and young adults (AYA) receiving tyrosine kinase inhibitors (TKI) therapy for chronic-phase chronic myeloid leukemia (CML) had similar prognoses to older patients despite also showing higher tumor burden at diagnosis.
Read More
Better HRQOL, Health Literacy Seen in Systemic Mastocytosis vs Mast Cell Activation Syndrome
August 22nd 2022Systemic mastocytosis and mast cell activation syndrome both negatively impact health-related quality of life (HRQOL), with mast cell activation syndrome patients reporting more significant impacts on everyday life.
Read More
Young Adults With SCD Show Better Hydroxyurea Adherence Than Children, Adolescents
August 6th 2022With adherence estimated at less than 50% in children, adolescents, and young adults, a recent study stresses the importance of treatment adherence for patients with sickle cell disease receiving hydroxyurea and the benefit for those who do.
Read More
Large-scale Studies Needed to Guide Newborn Screening for Rare Diseases
August 2nd 2022Despite the known potential benefits of newborn screening, the exact long-term clinical benefits and cost-effectiveness in large cohorts remain uncertain due to a lack of large-scale longitudinal research.
Read More
Heavy/Light Chain Assay Useful Marker in Cold Agglutinin Disease, Study Suggests
August 1st 2022Current standard modalities for detecting and quantifying monoclonal immunoglobin in patients with cold agglutinin disease lack adequate sensitivity. Heavy chain/light chain assay may be more effective.
Read More
GVHD May Mimic Eosinophilic GI Disorders Following Bone Marrow Transplant
July 30th 2022After years of dependence on systemic corticosteroids, ruxolitinib treatment was effective for an adolescent patient with graft-versus-host disease (GVHD) who was initially thought to have eosinophilic gastroenteritis.
Read More
Study Identifies Risk Factors for Thrombosis in Patients With AIHA
July 29th 2022This retrospective study and prospective follow-up provide insight into predictors of thrombotic episodes in patients with autoimmune hemolytic anemia (AIHA) and indicators that anticoagulant prophylaxis may be beneficial to certain patients.
Read More
Inflammatory Cytokine Profiles Are Similar in MDS and Unexplained Cytopenias, Study Suggests
July 21st 2022Clonal cytopenias of undetermined significance often manifest prior to myelodysplastic syndromes (MDS), and a recent study found similarities in the cytokine profiles of the distinct conditions.
Read More
Case Study Details Challenges in Eosinophilic Gastritis Management
July 21st 2022Nonspecific clinical symptoms can make identifying eosinophilic gastritis difficult, but detailed examination, biopsy, and testing can rule out other possible causes of eosinophilic infiltration of the gastric mucosa.
Read More
Targeting β Cells May Hold Promise for Preventing and Treating T1D
July 7th 2022Although the autoimmune response that reduces β cell numbers has often been the focus of research in type 1 diabetes (T1D), findings from a new study suggest proinflammatory signaling in islet β cells may play a significant role in disease progression.
Read More
Hypomethylating Agents Can Produce Long Remission of MPNs but May Contribute to Morbidity, Mortality
July 4th 2022Hypomethylating agents are a widely used treatment option in acute myeloid leukemia secondary to myeloproliferative neoplasms (MPNs), but careful monitoring of thromboembolic risk is needed for optimal outcomes.
Read More
Assessing Longitudinal Trends in Essential Thrombocythemia, Polycythemia Vera Blood Counts
July 2nd 2022A recent study identified trends in blood counts, but did not find statistically significant associations between achieving hematological remission and clinical outcomes in polycythemia vera (PV) or essential thrombocythemia (ET).
Read More